Members of our Executive Leadership Team discuss TDI. Learn what makes us unique, how we stand to impact the economy of NYC, and how we are changing the way that new drugs are developed across the Tri-I and beyond.

Laurie Glimcher, MD
Founder, Tri-I TDI
Stephen and Suzanne Weiss Dean, Weill Cornell Medicine, Emeritus, 2012 — 2016

Marc Tessier-Lavigne, PhD
Founder, Tri-I TDI
President, The Rockefeller University, Emeritus, 2011 — 2016

Michael A. Foley, PhD
Sanders Director, Emeritus
Tri-Institutional Therapeutics Discovery Institute,  2014- -2018

Craig B. Thompson, MD
Founder, Tri-I TDI
President & CEO, Memorial Sloan Kettering Cancer Center, Emeritus, 2010 — 2022